The Ashwin

The Ashwin is a monthly webzine for AO Labs' customers -- Jan., 2002 Edition
Formatted to 600 pixel width for ease of reading and hardcopy reproduction from the browser.
Related Links: Ashwin Archives Letters to the Editor - (Submissions)


The Year in Review: 2001

cansema-tonicImportant Developments / Achievements at "AO" For 2001

"Save for the final moment of your final hour, a time known only to your Creator, there is, for every disease & every affliction, a God-given botanical cure - if you only knew where to find it - and would apply the faith and the persistence to fully employ its original healing purpose..."

The Ashwin Letters: Musings from the Divine Physicians

Cansema Revamped & CanSupport Introduced

{xtypo_dropcap}T{/xtypo_dropcap}his year saw changes to the internal Cansema formulas (which prior to 2001, existed solely of the black topical salve and two internal variations - "capsules" and Tonic (I)). Based on positive feedback from clinicians with which ?? Labs is associated, we introduced Cansema Tonic III in February - a cancer-fighting nutraceutical cocktail consisting of extracts of graviola (annona muricata), andrographis (peniculata), and chapparal (larrea mexicata and tridentata), all infused and stabilized in an aloe vera base for maximum absorption.

The response from the international community of alternative health care practitioners has been quite positive. One of the problems we had with many patients and their clinicians with the first Cansema Tonic was emetic responses tied to some of the herbal alkaloids in the product. This, in turn, lead to patient compliance issues. Despite clear instructions that patients should only take the product on a full stomach, a surprising number of users would disregard or ignore these warnings altogether. In quite a number of advanced Stage IV cases, "eating a full meal" didn't exist, such that it wasn't practically possible to follow the instructions to begin with.

This coming year (2002) we will be following the success of Tonic III with several new variations of Cansema Tonic. Each formula will have its own areas of strength as to cancer type(s), cancerolytic methods of action, ease of use, etc.

Internal Usage:
Salve vs. Tonic III

Cansema Black Topical Salve is probably the world's best-selling, best-known escharotic salve for the removal of skin cancers. Patterned after its predecessor, HerbVeil 8 (marketed under an alliance with the now defunct Lenex Laboratories), Cansema has been used by end users and doctors in countries as far as Ukraine, Japan, Australia, New Zealand, Equador, Colombia, Trinidad, the U.S., Canada - to name a few.

Nonetheless, there ARE cases with Cansema Salve is not the best topical choice for cancer removal. As we have said repeatedly, in these pages, and in the Cansema FAQ pages, issues of pain management are often pronounced when the size of the cancer is large - perhaps in the range of 3 cm. or greater, although this varies greatly. In addition, the location of the cancer has a great deal to do with calculating pain management and the type(s) of analgesics that may or may not be in order. Of particular sensitivity are cancers in the dermal layers or close thereto located in or on the breasts, ears, lips, genitalia, areas covering regular joint movement - such as around the underarms, elbow (anterior), also anterior area above trapezium or patella, etc.

For these cases we began recommending the topical use of the Cansema Tonic III, based on positive feedback we had received from some of our doctors. To date, the results - for both humans and animals, has been quite encouraging. Though not nearly as aggressive (and there is the inconvenience of dealing with a material with a much lower viscosity) or as fast-acting, Tonic III holds enormous potential in the area of topical use. ? ??

CanSupport Brain Cancer bundle
The CanSupport products, now available in both aloe-infused, bioavailable liquid form, as well as capsule form, came out of a combination of our own research with that of Raintree Nutrition, which has focussed extensively on the medicinal properties of Amazonian herbs - primarily from Brazil. (This work is not to be confused with our own projects in Equador and Peru - which have given rise to other herb-based products we carry that come from the Western Amazon.)

Taking the known effects of these herbal compounds and combining them with Tonic III and the alkalizing effects of HRx (see article at right) produced ten distinct nutraceutical "bundles" - one for each of ten different cancer "types."

Although the response from our clinicians has been quite good across the board, it has been our experience that doctors will often make substitutions for their patients. We are often asked to substitute two bottles of the Cansema Capsules for Tonic III or one case; or CanSupport capsules instead of the liquid; H3O instead of HRx (as both alkalize, despite H3O initial high acidic pH), etc. Sometimes dramatic changes in response can come from small changes in protocol. If you are working with a practitioner who is familiar with our products, do not be surprised if they make adjustments in your regimen in response to your progress.

QuikHeal Salve
   Breaking Into Bio-Oxidative

If you understand the importance of oxygenation as it pertains to both preventing and eradicating cancer (see sidebar on Otto Warburg at right), you cannot ignore bio-oxidative forms of therapy - which comprise medicinal uses for both ozone and hydrogen peroxide. On this subject what is hornbook science in Germany and Russia, has, in the name of profit, been labelled quackery in the U.S. and Canada. This will change in time and the quackery label will end - (all Flat Earth Societies eventually must eventually lose their following).

In recognition of its importance, AO introduced Quikheal Quick Healing Salves in May. The company has had plans to inexpensively provide hydrogen peroxide, but these plans have been detailed, due to the complexity of setting up distribution for 35% H2O2 in various countries - made complicated by its HazMat (Hazardous Material) rating.

But expect AO to have its own product out in the first quarter.